Class information for: |
Basic class information |
| ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
|---|---|---|---|
| 15526 | 637 | 30.3 | 70% |
Classes in level above (level 2) |
Terms with highest relevance score |
| Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|---|
| 1 | CONTRALATERAL PROPHYLACTIC MASTECTOMY | Author keyword | 36 | 83% | 3% | 20 |
| 2 | BILATERAL BREAST CANCER | Author keyword | 31 | 51% | 7% | 43 |
| 3 | CONTRALATERAL BREAST CANCER | Author keyword | 19 | 48% | 5% | 29 |
| 4 | BILATERAL BREAST CARCINOMA | Author keyword | 18 | 89% | 1% | 8 |
| 5 | PROPHYLACTIC MASTECTOMY | Author keyword | 13 | 32% | 5% | 35 |
| 6 | UNILATERAL BREAST CANCER | Author keyword | 8 | 100% | 1% | 5 |
| 7 | SICK LOBE THEORY | Author keyword | 6 | 80% | 1% | 4 |
| 8 | SYNCHRONOUS BREAST CANCER | Author keyword | 6 | 71% | 1% | 5 |
| 9 | CONTRALATERAL MASTECTOMY | Author keyword | 6 | 100% | 1% | 4 |
| 10 | MULTICENTRIC | Author keyword | 4 | 18% | 3% | 22 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
| Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | 1ST PRIMARY | 53 | 95% | 3% | 18 |
| 2 | OPPOSITE BREAST | 23 | 86% | 2% | 12 |
| 3 | WHOLE ORGAN | 10 | 46% | 3% | 17 |
| 4 | UNILATERAL BREAST CANCER | 6 | 80% | 1% | 4 |
| 5 | CONTRALATERAL PROPHYLACTIC MASTECTOMY | 5 | 17% | 4% | 26 |
| 6 | CONTRALATERAL BREAST | 5 | 11% | 6% | 39 |
| 7 | INDIVIDUAL FOCI | 4 | 75% | 0% | 3 |
| 8 | MULTICENTRICITY | 3 | 17% | 3% | 18 |
| 9 | SUBCUTANEOUS MASTECTOMY | 3 | 12% | 4% | 25 |
| 10 | LIMITED EXTENT | 3 | 60% | 0% | 3 |
Journals |
Reviews |
| Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
|---|---|---|---|---|
| Epidemiology of contralateral breast cancer | 1999 | 168 | 43 | 60% |
| Bilateral breast cancers | 2014 | 6 | 74 | 49% |
| Prophylactic Mastectomy: Who Needs It, When and Why | 2015 | 1 | 39 | 64% |
| Evolving paradigms in multifocal breast cancer | 2015 | 1 | 52 | 60% |
| Contralateral Prophylactic Mastectomy After Unilateral Breast Cancer A Systematic Review and Meta-analysis | 2014 | 4 | 68 | 57% |
| Prognosis of synchronous bilateral breast cancer: a review and meta-analysis of observational studies | 2014 | 2 | 24 | 83% |
| Contralateral prophylactic mastectomy in women with breast cancer: trends, predictors, and areas for future research | 2013 | 8 | 38 | 68% |
| Effect of multifocality and multicentricity on outcome in early stage breast cancer: a systematic review and meta-analysis | 2014 | 3 | 36 | 64% |
| Increasing trend of contralateral prophylactic mastectomy: What are the factors behind this phenomenon? | 2014 | 3 | 32 | 63% |
| Contralateral prophylactic mastectomy and survival: report from the National Cancer Data Base, 1998-2002 | 2013 | 9 | 34 | 53% |
Address terms |
| Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
|---|---|---|---|---|---|
| 1 | RISK ASSESSMENT CLIN | 2 | 67% | 0.3% | 2 |
| 2 | PATHOL CLIN CYTOL | 2 | 16% | 1.4% | 9 |
| 3 | ACT BREAST CANC TREATMENT GRP | 1 | 50% | 0.2% | 1 |
| 4 | BEIJING MATERN HOSP | 1 | 50% | 0.2% | 1 |
| 5 | BREAST TEAM | 1 | 50% | 0.2% | 1 |
| 6 | CANC STUDIESCANC EPIDEMIOL GRP | 1 | 50% | 0.2% | 1 |
| 7 | CLIN CANC EPIDEMIOL CLIN SCI | 1 | 50% | 0.2% | 1 |
| 8 | CLIN GROSSHADERN IBE | 1 | 50% | 0.2% | 1 |
| 9 | DIAGNOST RADIOLSEODAEMUM KU | 1 | 50% | 0.2% | 1 |
| 10 | HOP HAUTE LEVEQUE | 1 | 50% | 0.2% | 1 |
Related classes at same level (level 1) |
| Rank | Relatedness score | Related classes |
|---|---|---|
| 1 | 0.0000127202 | BREAST RECONSTRUCTION//SKIN SPARING MASTECTOMY//NIPPLE SPARING MASTECTOMY |
| 2 | 0.0000114207 | VERY YOUNG WOMEN//YOUNG BREAST CANCER//YOUNG AGE |
| 3 | 0.0000112972 | DUCTAL CARCINOMA IN SITU//LOBULAR CARCINOMA IN SITU//FLAT EPITHELIAL ATYPIA |
| 4 | 0.0000106989 | PERITUMORAL VASCULAR INVASION//BLOOD VESSEL INVASION//AXILLARY NODE STATUS |
| 5 | 0.0000106788 | BRCA1//BRCA2//HEREDITARY BREAST CANCER |
| 6 | 0.0000103055 | BREAST MRI//BREAST NEOPLASMS MR//MR MAMMOGRAPHY |
| 7 | 0.0000089633 | MULTIPLE PRIMARY MALIGNANCIES//MULTIPLE PRIMARY MALIGNANT NEOPLASMS//MULTIPLE PRIMARY NEOPLASMS |
| 8 | 0.0000088955 | GENETIC TESTING//GENETIC COUNSELING//JOURNAL OF GENETIC COUNSELING |
| 9 | 0.0000082359 | GASTRIC METASTASIS//INVASIVE LOBULAR CARCINOMA//PLEOMORPHIC LOBULAR CARCINOMA |
| 10 | 0.0000081468 | TUMOR CLONALITY//CLONAL REMISSION//M27 BETA |